Skip to main content

CORRECTION article

Front. Chem., 22 November 2022
Sec. Inorganic Chemistry
Volume 10 - 2022 | https://doi.org/10.3389/fchem.2022.1075376

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

This article is a correction to:

  1. Rational Design of a Gd(III)–Cu(II) Nanobooster for Chemodynamic Therapy Against Cancer Cells

    1. Read original article
Xin-Ya ShiXin-Ya Shi1Ting-Xiao ShenTing-Xiao Shen2Ao-Lin ZhangAo-Lin Zhang2Li-Tao TanLi-Tao Tan2Wen-Chang ShenWen-Chang Shen2Hai-Jiang ZhongHai-Jiang Zhong2Shun-Lin Zhang Shun-Lin Zhang3*Yu-Lan Gu Yu-Lan Gu1*Lei Shen Lei Shen2*
  • 1Department of Oncology, Changshu No. 2 People’s Hospital, Changshu, China
  • 2Jiangsu Laboratory of Advanced Functional Materials, College of Material Engineering, Changshu Institute of Technology, Changshu, China
  • 3State Key Laboratory of Materials-Oriented Chemical Engineering, College of Chemical Engineering, Nanjing Tech University, Nanjing, China

A Corrigendum on
Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

by Shi X-Y, Shen T-X, Zhang A-L, Tan L-T, Shen W-C, Zhong H-J, Zhang S-L, Gu Y-L and Shen L (2022). Front. Chem. 10:856495. doi: 10.3389/fchem.2022.856495

In the original article, there was an error in Figure 6D, page 6, as published. The corrected figure appears below.

FIGURE 6
www.frontiersin.org

FIGURE 6. (A–C) In vitro MTT assay of HeLa, HepG2, and HT29 cells was treated with ligand H4L and complex NPs; trypan blue fluorescent staining of the control group for (D) HeLa cells, (E) HepG2 cells, and (F) HT29 cells; Complex NPs for (G) HeLa cells (H) HepG2 cells (I) HT29 cells.

In the original article, there was an error in the caption for Figure 6, page 6, as published. The corrected caption appears below.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: tetrazole, Gd(III)–Cu(II), crystal structure, chemodynamic therapy, nanobooster

Citation: Shi X-Y, Shen T-X, Zhang A-L, Tan L-T, Shen W-C, Zhong H-J, Zhang S-L, Gu Y-L and Shen L (2022) Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells. Front. Chem. 10:1075376. doi: 10.3389/fchem.2022.1075376

Received: 20 October 2022; Accepted: 02 November 2022;
Published: 22 November 2022.

Edited and reviewed by:

Clara S. B. Gomes, New University of Lisbon, Portugal

Copyright © 2022 Shi, Shen, Zhang, Tan, Shen, Zhong, Zhang, Gu and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shun-Lin Zhang, emhhbmdzbDkzQG5qdGVjaC5lZHUuY24=; Yu-Lan Gu, Z3V5dWxhbkAyNjMubmV0; Lei Shen, bGVpc2hlbkBjc2xnLmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.